» Articles » PMID: 36907319

Therapeutic Strategies of Small Molecules in the Microbiota-gut-brain Axis for Alcohol Use Disorder

Overview
Specialty Pharmacology
Date 2023 Mar 12
PMID 36907319
Authors
Affiliations
Soon will be listed here.
Abstract

The microbiota-gut-brain axis (MGBA) is important in maintaining the structure and function of the central nervous system (CNS) and is regulated by the CNS environment and signals from the peripheral tissues. However, the mechanism and function of the MGBA in alcohol use disorder (AUD) are still not completely understood. In this review, we investigate the underlying mechanisms involved in the onset of AUD and/or associated neuronal deficits and create a foundation for better treatment (and prevention) strategies. We summarize recent reports focusing on the alteration of the MGBA in AUD. Importantly, we highlight the properties of small-molecule short-chain fatty acids (SCFAs), neurotransmitters, hormones, and peptides in the MGBA and discusses their usage as therapeutic agents against AUD.

Citing Articles

Treatment of preterm brain injury via gut-microbiota-metabolite-brain axis.

Li L, Liu T, Shi Y CNS Neurosci Ther. 2023; 30(1):e14556.

PMID: 38108213 PMC: 10805406. DOI: 10.1111/cns.14556.


Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury.

Wang Z, Luo C, Zhou E, Sandhu A, Yuan X, Williams G Int J Mol Sci. 2023; 24(10).

PMID: 37240148 PMC: 10218145. DOI: 10.3390/ijms24108805.

References
1.
Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song B . Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis. Int J Mol Sci. 2020; 21(7). PMC: 7177420. DOI: 10.3390/ijms21072316. View

2.
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y . The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. 2019; 5(2):eaau8317. PMC: 6365110. DOI: 10.1126/sciadv.aau8317. View

3.
Mistarz N, Andersen K, Nielsen A, Goudriaan A, Michel T, Skot L . Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review. Neurosci Biobehav Rev. 2021; 125:608-626. DOI: 10.1016/j.neubiorev.2021.02.038. View

4.
Wolstenholme J, Saunders J, Smith M, Kang J, Hylemon P, Gonzalez-Maeso J . Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice. Nat Commun. 2022; 13(1):6198. PMC: 9581985. DOI: 10.1038/s41467-022-34054-6. View

5.
Leclercq S, Le Roy T, Furgiuele S, Coste V, Bindels L, Leyrolle Q . Gut Microbiota-Induced Changes in β-Hydroxybutyrate Metabolism Are Linked to Altered Sociability and Depression in Alcohol Use Disorder. Cell Rep. 2020; 33(2):108238. DOI: 10.1016/j.celrep.2020.108238. View